✦ LIBER ✦

ChemInform Abstract: Modern Compounds for the Treatment of Type II Diabetes: Achievements and Perspectives

✍ Scribed by V. V. LIPSON; V. V. POLTORAK; N. I. GORBENKO

Publisher: John Wiley and Sons
Year: 2010
Weight: 24 KB
Volume: 29
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.199812292

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Synthetic Approache

ChemInform Abstract: Synthetic Approaches to Benzofuran-Containing Insulin Sensitivity Enhancer Compounds for Treatment of Type II Diabetes.

✍ B. E. HUFF; C. L. LEFFELMAN; M. E. LETOURNEAU; K. A. SULLIVAN; J. A. WARD; J. R. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 30 KB 👁 1 views

ChemInform Abstract: The Thiazolidinedio

ChemInform Abstract: The Thiazolidinediones — A Novel Approach for the Treatment of Type-2 Diabetes

✍ H. BETHGE; H. U. HAERING 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

ChemInform Abstract: Design of Potent an

ChemInform Abstract: Design of Potent and Selective GPR119 Agonists for Type II Diabetes.

✍ Jason W. Szewczyk; et al. et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 12 KB

## Abstract Dual termini optimization of a bis‐piperidine‐based GPR119 agonist affords an analogue possessing improved potency, selectivity, and formulation profile, but modest physical properties.

ChemInform Abstract: Aleglitazar (I), a

ChemInform Abstract: Aleglitazar (I), a New, Potent, and Balanced Dual PPARα/γ Agonist for the Treatment of Type II Diabetes.

✍ Peter Mohr; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 13 KB 👁 1 views

ChemInform Abstract: New Perspectives fo

ChemInform Abstract: New Perspectives for the Treatment of HIV Infections

✍ E. DE CLERCQ 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB 👁 2 views

ChemInform Abstract: Piperidinyl-2-phene

ChemInform Abstract: Piperidinyl-2-phenethylamino Inhibitors of DPP-IV for the Treatment of Type 2 Diabetes.

✍ John W. Benbow; et al. et al. 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 13 KB 👁 1 views